Quest Diagnostics and Paige Form Collaboration to Advance AI-generated Pathology Insights to Improve Cancer Diagnosis and Care streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Quest Diagnostics strikes deal with pathology AI startup Paige
Quest Diagnostics strikes deal with pathology AI startup Paige
Print
Quest Diagnostics is working with artificial-intelligence startup Paige to try to identify new biomarkers of cancer and other diseases and develop new software products, the companies said Tuesday.
The companies will apply machine learning from Paige, a spinoff of New York City-based Memorial Sloan Kettering Cancer Center that uses AI to help diagnose cancer patients, to analyze digitized pathology slides from Quest, including from the clinical laboratory company s AmeriPath and Dermpath pathology services businesses.
Paige, a startup based in New York City, was founded in 2017 and in 2019 was granted breakthrough-device designation by the Food and Drug Administration.
Quest Diagnostics and Paige Form Collaboration to Advance AI-generated Pathology Insights to Improve Cancer Diagnosis and Care prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Inform Diagnostics and Paige Enter Collaboration to Integrate Digital Solutions with Anatomic Pathology Diagnostics
News provided by
Share this article
Share this article
IRVING, Texas and NEW YORK, May 12, 2021 /PRNewswire/ Inform Diagnostics, a leading U.S. anatomic pathology provider, and Paige, a global leader in AI-based cancer diagnostic software for digital pathology, today announced an agreement to accelerate the use and optimization of digital pathology workflows at Inform Diagnostics.
Inform Diagnostics plans to immediately begin the implementation of the FullFocus
™ digital pathology viewer. FullFocus
™ will integrate into the Inform Diagnostics subspecialty anatomic pathology workflows and laboratory information system (LIS). The integrated solution will allow for more streamlined logistics, faster turnaround times for pathology results, and more efficient support of internal and external laboratory service models.
Epredia And Paige Announce Global Commercial Distribution Agreement For Digital Pathology Software
PORTSMOUTH, N.H., March 17, 2021 /PRNewswire/ Epredia, a global leader in precision cancer diagnostics, and Paige, a global leader in AI-based diagnostic software in pathology, have announced today that they have entered into a commercial distribution agreement for Paige s comprehensive portfolio of diagnostic software solutions.
Under the terms of this agreement, Epredia has been appointed as a global distribution partner of the entire Paige portfolio of imaging diagnostic solutions. In addition, Epredia will have exclusive distribution rights in Japan. In the second quarter of 2021, Epredia will begin to commercialize the Paige solutions alongside existing Epredia products in the United States and major European Countries, further strengthening its comprehensive digital pathology portfolio that already includes the best-in-class CE-marked 3DHistech P1000 scanner .